Opinion

Video

Patient Selection and Switching Patients to Subcutaneous Infliximab

Author(s):

Jean-Frederic Colombel, MD

Jean-Frederic Colombel, MD, examines considerations for transitioning patients from intravenous to subcutaneous infliximab and evaluates the role of subcutaneous infliximab within the evolving landscape of inflammatory bowel disease treatments.

  1. For patients currently receiving IV infliximab (originator or biosimilar), are there any considerations for switching them to subcutaneous infliximab?
  2. How will subcutaneous infliximab fit in with the growing IBD treatment landscape?
Related Videos
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Highlighting the Danger of SCI Progression during iTTP Remission, with Shruti Chaturvedi, MBSS, MS
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Related Content
Credit: Christopher Gottschalk, MD I Yale Medicine
December 9th 2024

Atogepant Improves Quality of Life in Individuals with Chronic, Episodic Migraine

Chelsie Derman
Medical Ethics Unpacked: Ethical Considerations for Euthanasia and Medically-Assisted Suicide
November 22nd 2024

Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medical Assistance in Dying

Steven Levine, MD Dominic Sisti, PhD
Allison Malcolm, MBBS | Credit: Forster Private Hospital
December 9th 2024

Autonomic Modulation May Benefit Patients with Constipation-Predominant IBS

Abigail Brooks, MA
Medical Ethics Unpacked:
November 22nd 2024

Medical Ethics Unpacked: Ethical Foundations and Background of Euthanasia & Medically-Assisted Suicide

Steven Levine, MD Dominic Sisti, PhD
Kristin Shimano, MD | Credit: UCSF Benioff Children's Hospitals
December 8th 2024

Eltrombopag Bests Standard of Care as First-Line Therapy in Pediatric Immune Thrombocytopenia

Patrick Campbell
Female patient discussing iron deficiency with care provider. | Credit: Shutterstock
December 8th 2024

Universal 25 µg/L Threshold for Iron Deficiency is Cost-Effective, Could Improve Management in US Women

Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.